Kandace P McGuire

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. ncbi MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?
    Kandace P McGuire
    Department of Surgery, Magee Womens Hospital, University of Pittsburgh, 300 Halket St, Pittsburgh, PA, USA
    Ann Surg Oncol 18:3149-54. 2011
  2. ncbi Predictors of pathologic complete response after standard neoadjuvant chemotherapy in triple-negative breast carcinoma
    James A Kraus
    Department of Pathology, Magee Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Appl Immunohistochem Mol Morphol 20:334-9. 2012
  3. ncbi Semiquantitative hormone receptor level influences response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast cancer
    Rohit Bhargava
    Department of Pathology, Magee Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Mod Pathol 24:367-74. 2011

Collaborators

Detail Information

Publications3

  1. ncbi MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?
    Kandace P McGuire
    Department of Surgery, Magee Womens Hospital, University of Pittsburgh, 300 Halket St, Pittsburgh, PA, USA
    Ann Surg Oncol 18:3149-54. 2011
    ..We seek to quantify this MRI/pathology discrepancy and determine if the accuracy of MRI post NAC varies with tumor subtype...
  2. ncbi Predictors of pathologic complete response after standard neoadjuvant chemotherapy in triple-negative breast carcinoma
    James A Kraus
    Department of Pathology, Magee Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Appl Immunohistochem Mol Morphol 20:334-9. 2012
    ..E-cadherin expression as a predictor of pathologic complete response in triple-negative tumors should be further assessed on larger number of cases...
  3. ncbi Semiquantitative hormone receptor level influences response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast cancer
    Rohit Bhargava
    Department of Pathology, Magee Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Mod Pathol 24:367-74. 2011
    ..This information can be utilized to counsel patients considered for neoadjuvant chemotherapy and the same principle could be applied in the adjuvant setting...